Olaparib as Maintenance Treatment Following First-line Platinum-based
   Chemotherapy (PBC) in Patients With a Germline BRCA Mutation and
   Metastatic Pancreatic Cancer (mPC): Phase III POLO Trial

Titel:: Olaparib as Maintenance Treatment Following First-line Platinum-based Chemotherapy (PBC) in Patients With a Germline BRCA Mutation and Metastatic Pancreatic Cancer (mPC): Phase III POLO Trial
Dokumenttyp:: Meeting Abstract
Autor(en):: Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; Reinacher-Schick, A.; Tortora, G.; Alguel, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K. Y.; Schlienger, K.; Locker, G. Y.; Kindler, H. L.
Zeitschriftentitel:: Pancreas
Jahr:: 2019
Band / Volume:: 48
Heft / Issue:: 10
Seitenangaben Beitrag:: 1433-1434
Print-ISSN:: 0885-3177
TUM Einrichtung:: Lehrstuhl für Tumormetabolismus (Prof. Algül)
BibTeX

Vorkommen: